P3B-14399-42210
3 vaccinations
7 coded responses
39 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 303 / GA
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
Y6R-31961-80608
Child or adolescent in my care · Female · 2022-07-01
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Pfizer-BioNTech
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
-
2021-04-21
Dose 2 — Pfizer-BioNTech
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-30
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-07-21
- 2021-10-20
-
2021-12-02
Dose 3 — Moderna
-
2021-12-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-06
Survey response — days 1–6 daily, dose 3MedDRA: Amenorrhoea, Discharge, Lactation puerperal increased, Uterine spasm — Feeling: Fair · Site: Pain · Joint painsFree text: I have had uterine cramps and dramatically increased clear discharge since receiving the booster shot. I have been lactating and not menstruating for the last 9 months so initially thought it might be menstruation returning, but it is not.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-07
Survey response — days 1–6 daily, dose 3MedDRA: Medical counselling, Uterine spasm — Feeling: Good · Muscle or body aches · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Still experiencing substantial uterine cramps ever since receiving my booster shot, with no discernible cause. · Healthcare visit (other): Have consulted with my OBGYN regarding persistent uterine crampsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-07
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-08
Survey response — days 1–6 daily, dose 3MedDRA: Uterine spasm — Feeling: Good · Muscle or body achesFree text: Still experiencing uterine cramps without bleedingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-08
-
2021-12-09
Survey response — day 7, dose 3MedDRA: Uterine spasm — Feeling: Good · Muscle or body achesFree text: Uterine crampsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-13
Call successfulDoes not wish to fill out VAERS report
- 2021-12-16
-
2021-12-23
Survey response — day 21, dose 3MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, cough, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Survey response — day 28, dose 3MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Cough, runny nose, congestion, sore throat (entire family tested negative for COVID 19 via rapid antigen test)MedDRA releases: 2024-11 · check-in free text available
- 2022-01-06
- 2022-01-13
- 2022-03-03
-
2022-06-02
Survey response — 6 months, dose 3MedDRA: Dysmenorrhoea, Endometrial hyperplasia, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Endometrial hyperplasia and dysmenorrhea · Healthcare visit (other): Ultrasound and prescription treatmentMedDRA releases: 2024-11 · check-in free text available
-
2022-06-02
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-06-03
- 2022-06-03
- 2022-12-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-07 | Successful 2021-12-13 |
Does not wish to fill out VAERS report |
| 2022-06-02 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): I have had uterine cramps and dramatically increased clear discharge since receiving the booster shot. I have been lactating and not menstruating for the last 9 months so initially thought it might be menstruation returning, but it is not.
Systemic reaction (other): Still experiencing substantial uterine cramps ever since receiving my booster shot, with no discernible cause.
Healthcare visit (other): Have consulted with my OBGYN regarding persistent uterine cramps
Systemic reaction (other): Still experiencing uterine cramps without bleeding
Release 10 — day 7, dose 3
Systemic reaction (other): Uterine cramps
Release 10 — day 21, dose 3
Symptoms: Runny nose, cough, sore throat
Release 10 — day 28, dose 3
Symptoms: Cough, runny nose, congestion, sore throat (entire family tested negative for COVID 19 via rapid antigen test)
Release 11 — 6 months, dose 3
Symptoms: Endometrial hyperplasia and dysmenorrhea
Healthcare visit (other): Ultrasound and prescription treatment
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| HCVO | Uterine spasm | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Endometrial hyperplasia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Amenorrhoea | · | · | ✓ |
| SRO | Discharge | · | · | ✓ |
| SRO | Lactation puerperal increased | · | · | ✓ |
| SRO | Uterine spasm | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release